Literature DB >> 721947

Comparison of immunogenicity of a whole virion and a subunit influenza vaccine in adults.

D W Ortbals, H Liebhaber.   

Abstract

The immunogenicity and reactogenicity of a whole virus (Merck Sharp & Dohme) and a subunit (Wyeth) influenza A/New Jersey/76 vaccine were compared in a group of 214 normal adult subjects. Both the seroconversion rate and the magnitutde of hemagglutination inhibition antibody response were significantly (P less than 0.01) lower in the recipients of the subunit vaccine, whereas there were no significant differences in local or systemic reactions between the two preparations. On the basis of these data, we question the previous Public Health Service recommendation that one dose of either preparation of the influenza A/New Jersey/76 vaccine is equally efficacious in individuals over 24 years of age.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 721947      PMCID: PMC275266          DOI: 10.1128/jcm.8.4.431-434.1978

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  COMPARISONS OF SEROLOGIC AND FEBRILE RESPONSES IN HUMANS TO VACCINATION WITH INFLUENZA A VIRUSES OR THEIR HEMAGGLUTININS.

Authors:  F M DAVENPORT; A V HENNESSY; F M BRANDON; R G WEBSTER; C D BARRETT; G O LEASE
Journal:  J Lab Clin Med       Date:  1964-01

2.  Influenza immunization in chronic bronchitis: local and systemic immune response.

Authors:  P A Gross; D W Barry; N D'Esopo
Journal:  Am Rev Respir Dis       Date:  1976-08

3.  Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in man.

Authors:  D W Barry; R E Mayner; E Staton; R C Dunlap; S C Rastogi; J E Hannah; R J Blackburn; D F Nortman; P R Graze
Journal:  Am J Epidemiol       Date:  1976-07       Impact factor: 4.897

4.  Inactivated influenza vaccine efficacy: diminished antigenicity of split-product vaccines in mice.

Authors:  D W Barry; E Staton; R E Mayner
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

5.  The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses.

Authors:  D Hobson; R L Curry; A S Beare; A Ward-Gardner
Journal:  J Hyg (Lond)       Date:  1972-12

6.  Killed subunit influenza vaccine in children.

Authors:  C F Phillips; C A Phillips; W E Hodgkin; B R Forsyth; B A Rubin; M E Geraghty
Journal:  Pediatrics       Date:  1973-09       Impact factor: 7.124

7.  Purified influenza virus vaccine. A study of viral reactivity and antigenicity.

Authors:  F B Peck
Journal:  JAMA       Date:  1968-12-02       Impact factor: 56.272

8.  Respiratory virus vaccines. 3. Some biological properties of Sephadex-purified ether-extracted influenza virus antigens.

Authors:  F B Brandon; F Cox; G O Lease; E A Timm; E Quinn; I W McLean
Journal:  J Immunol       Date:  1967-04       Impact factor: 5.422

9.  From the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the Center for Disease Control, and the Bureau of Biologics of the Food and Drug Administration. Summary of clinical trials of influenza vaccines--II.

Authors:  P F Wright; R Dolin; J R La Montagne
Journal:  J Infect Dis       Date:  1976-12       Impact factor: 5.226

10.  Measles vaccination. V. The booster effect of purified hemagglutinin in children previously immunized with this product or formalin-killed vaccine.

Authors:  E Norrby; R Lagercrantz; S Gard
Journal:  Acta Paediatr Scand       Date:  1966-01
View more
  7 in total

1.  Characterization of humoral and cellular immune features of gamma-irradiated influenza vaccine.

Authors:  Fengjia Chen; Ho Seong Seo; Hyun Jung Ji; Eunji Yang; Jung Ah Choi; Jae Seung Yang; Manki Song; Seung Hyun Han; Sangyong Lim; Jae Hyang Lim; Ki Bum Ahn
Journal:  Hum Vaccin Immunother       Date:  2020-07-09       Impact factor: 3.452

2.  The antigenicity of whole virus versus subunit trivalent influenza vaccines -- a field trial in the Israel Defence Forces, 1978.

Authors:  J D Kark; M Lebiush; L Rannon; E Witztum; E Nili; R Kedem
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

Review 3.  Bench-to-bedside review: vaccine protection strategies during pandemic flu outbreaks.

Authors:  Joel V Chua; Wilbur H Chen
Journal:  Crit Care       Date:  2010-04-16       Impact factor: 9.097

4.  Comparative immunogenicity of live influenza viruses and their solubilized neuraminidases: results of mouse protection experiments.

Authors:  C Bottex; M F Burckhart; R Fontanges
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

5.  Effectiveness of Booster Measles-Mumps-Rubella Vaccination in Lower COVID-19 Infection Rates: A Retrospective Cohort Study in Turkish Adults.

Authors:  Erhan Yengil; Yusuf Onlen; Cahit Ozer; Mustafa Hambolat; Mehmet Ozdogan
Journal:  Int J Gen Med       Date:  2021-05-07

6.  Induction of influenza-specific mucosal immunity by an attenuated recombinant Sendai virus.

Authors:  Thuc-vy L Le; Elena Mironova; Dominique Garcin; Richard W Compans
Journal:  PLoS One       Date:  2011-04-18       Impact factor: 3.240

7.  Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools.

Authors:  Eita Sasaki; Haruka Momose; Yuki Hiradate; Keiko Furuhata; Mamiko Takai; Hideki Asanuma; Ken J Ishii; Takuo Mizukami; Isao Hamaguchi
Journal:  PLoS One       Date:  2018-02-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.